Galectin Therapeutics
GALT
GALT
33 hedge funds and large institutions have $12.6M invested in Galectin Therapeutics in 2013 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 10 increasing their positions, 3 reducing their positions, and 4 closing their positions.
Holders
33
Holders Change
+7
Holders Change %
+26.92%
% of All Funds
0.96%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
10
Reduced
3
Closed
4
Calls
–
Puts
$556K
Net Calls
-$556K
Net Calls Change
-$352K
Top Buyers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
First Manhattan
New York
| $13K | 1,667 | – | – |
|
|
OIA
27
Optimum Investment Advisors
Chicago,
Illinois
| $6K | 740 | – | – |
|
|
LTFS
28
Ladenburg Thalmann Financial Services
Miami,
Florida
| $4K | 500 | -26,072 | -98% |
|
29
AllianceBernstein
Nashville,
Tennessee
| $2K | 213 | – | – |
|
30
Citigroup
New York
| $2K | 236 | +236 | New |
|
|
PSI
31
Pinnacle Summer Investments
Fairfax,
Virginia
| $1K | 167 | – | – |
|
32
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | 112 | +12 | +12% |
|
33
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $1 | 157 | +157 | New |
|
|
EI
34
EAM Investors
Solana Beach,
California
| – | – | -152,854 | Closed |
|
|
TFCP
35
Twin Focus Capital Partners
Boston,
Massachusetts
| – | – | -107,363 | Closed |
|
36
Jane Street
New York
| – | – | -10,076 | Closed |
|
|
SSG
37
Summit Securities Group
New York
| – | – | -212 | Closed |
|